Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Stephanie Astrow, Hugh Reinhoff

Premium

Response Genetics has named Stephanie Astrow as vice president of research and development.

Astrow most recently was scientific director for oncology at Quest Diagnostics, where she worked to introduce new assays and services and coordinated with pharmaceutical companies to develop companion diagnostics. She also served as vice president and director of oncology at Pathway Diagnostics and vice president and scientific director at Impath.


Knome has appointed Hugh Reinhoff to its scientific advisory board.

Reinhoff is currently a managing director of Life Science Venture Partners, an adjunct scientist at the Children's Hospital Oakland Research Institute, and CEO of FerroKin BioSciences.

Reinhoff founded the nonprofit MyDaughtersDNA.org, and previously served as CEO and chairman of the board at DNA Sciences. He was also founding director of Healtheon, now known as WebMD Health. He holds an MD from the Johns Hopkins University School of Medicine.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.